Form 4 for CABA Cabaletta Bio, Inc.
Accepted 2023-10-19 00:00:00 ET · period of report 2023-10-19 · accession 0000950170-23-054234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-19 | 2023-10-19 | CABA | Binder Gwendolyn | See Remarks | M - OptEx | $1.01 | +11.0K | 31.0K | +55% | +$11.1K |
| DM | 2023-10-19 | 2023-10-19 | CABA | Binder Gwendolyn | See Remarks | S - Sale+OE | $13.36 | -11.0K | 20.0K | -35% | -$146.9K |
| D | 2023-10-19 | 2023-10-19 | CABA | Binder Gwendolyn | See Remarks | M - OptEx | $0.00 | -11.0K | 133.8K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-19 | M | A | 11,000 | $1.01 | 31,000 | D | — | — | |
| 2 | Common | Common Stock | 2023-10-19 | S | D | 10,592 | $13.32 | 20,408 | D | — | — | (F2) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 - $13.59. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2023-10-19 | S | D | 408 | $14.28 | 20,000 | D | — | — | (F3) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.15 - $14.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-10-19 | M | D | 11,000 | $0.00 | 133,756 | D | $1.01 · — to 2028-10-28 | 11,000 Common Stock | (F4) This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter. |